Satsuma Pharmaceuticals, Inc. (STSA) has a market capitalization of $36.47M and trades at $1.10. The 52-week range is 0.59-8.08.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.5, Earnings Per Share (EPS) of $-2.16.
The stock has a beta of 0.10, a last dividend of $1.5000, operates in the Healthcare sector.
